Enveric Biosciences, Inc.
ENVB
$1.45
$0.12089.09%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -33.64% | 91.63% | -27.98% | -11.16% | -44.89% |
Total Receivables | -- | -- | -- | -94.05% | -34.34% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -27.96% | 107.29% | -42.65% | -36.35% | -8.49% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 700.00% | -99.83% | -69.11% | -24.87% | 57.63% |
Total Current Assets | -31.59% | 76.80% | -36.97% | -21.41% | -32.92% |
|
|||||
Total Current Assets | -31.59% | 76.80% | -36.97% | -21.41% | -32.92% |
Net Property, Plant & Equipment | -9.80% | -12.59% | -16.83% | -9.23% | -10.42% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -50.00% | -33.33% | -24.96% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | -- | -- |
Total Assets | -30.45% | 65.52% | -35.65% | -20.84% | -31.62% |
|
|||||
Total Accounts Payable | 55.56% | 28.27% | -9.47% | 25.31% | -75.18% |
Total Accrued Expenses | -55.19% | -47.49% | 273.97% | 43.54% | -52.82% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -14.69% | 117.53% | 6.59% | -93.56% |
Total Other Current Liabilities | -- | -14.69% | 117.53% | 6.59% | -93.56% |
Total Current Liabilities | 15.14% | -20.49% | 77.51% | 30.05% | -72.75% |
|
|||||
Total Current Liabilities | 15.14% | -20.49% | 77.51% | 30.05% | -72.75% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 15.14% | -20.49% | 77.51% | 30.05% | -72.75% |
|
|||||
Common Stock & APIC | 0.68% | 4.17% | 0.80% | 0.56% | 0.77% |
Retained Earnings | -2.33% | -2.06% | -3.07% | -2.07% | -1.90% |
Treasury Stock & Other | 4.10% | -0.59% | -11.12% | 5.56% | -2.66% |
Total Common Equity | -44.23% | 145.96% | -59.69% | -26.91% | -16.59% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -44.23% | 145.96% | -59.69% | -26.91% | -16.59% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -44.23% | 145.96% | -59.69% | -26.91% | -16.59% |
|